Project Grant T32CA279363
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$359K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
The University of Texas Southwestern Medical Center has been awarded a $432,326 Project Grant by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. This 5-year grant supports the Translational Cancer Biology (TCB) T32 Training Program, which will provide funding for 2 pre-doctoral and 4 post-doctoral trainees to conduct bench-to-bedside cancer research. The program aims to train high-quality cancer researchers with the intellectual,...
The National Cancer Institute (NCI) awarded a $178,541 Project Grant to Oregon Health & Science University (OHSU) under the Cancer Research Manpower (CFDA 93.398) program. The 5-year grant, starting on January 15, 2025, will fund the "Experimental Therapeutics in Cancer (ETC) Training Program" to train a total of 9 PhD and MD postdoctoral fellows in oncological drug development and translational cancer research. The ETC program will leverage OHSU's expertise as an NCI-designated...
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Research Manpower program (CFDA 93.398) to The University of Texas MD Anderson Cancer Center in the amount of $139,247 with a period of performance from June 1, 2025 to May 31, 2030. The purpose of this grant is to conduct research on harnessing extrachromosomal DNA (ecdna) detection in antigen-presenting cells to enhance anti-tumor immunity. The key objectives are to: 1) Mechanistically examine how ecdna detection in...
This federal Project Grant award for $166,428 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support a new T32 predoctoral training program at Stanford University to prepare the next generation of multi-disciplinary cancer researchers. The program, titled "Genetic and Environmental Basis of Cancer Risk and Disparities (GECARD)," will provide integrative training across fields like epidemiology, biostatistics, genetics, environmental health, and...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,226,250.00 to The University of Texas M.D. Anderson Cancer Center to investigate the role of DNA methylation in controlling retrotransposons and governing adult stem cell fates. The 5-year award, running from August 1, 2024 to May 31, 2029, will examine how DNA methylation regulates retrotransposons and impacts adult stem...
The National Cancer Institute (NCI) awarded Emory University a $312,737 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program. The "Georgia Science Education Initiative NCI YES (GA-YES)" program aims to recruit and train high school students underrepresented in STEM careers, with a focus on rural and lower socioeconomic status students, in cancer research and disparities. Key program components include: 1) a summer mentored cancer research training...
The National Cancer Institute (NCI) awarded a $1,036,293 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of California, Los Angeles (UCLA) to establish the Neuro-Oncology Translational Research Training Program (NOTR-TP). The grant, effective from February 1, 2025 to June 30, 2030, will support a multidisciplinary translational research program focused on brain cancer, including 1 predoctoral and 3 postdoctoral trainees. The program aims to train the next...
The University of Texas Health Science Center of San Antonio (UTHSCSA) received a $978,159 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into purinergic receptor antagonist therapeutics for treating metastatic renal cancer from July 1, 2023 through June 30, 2026. As the prime awardee, UTHSCSA will conduct research to develop medical solutions for cancer on the battlefield and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The 5-year program, running from September 1, 2024 to August 31, 2029, aims to train the next generation of GI cancer researchers across basic science, translational, clinical, epidemiological, and...
The National Cancer Institute (NCI) awarded a $192,240 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to The University of Texas MD Anderson Cancer Center. The project, titled "Unraveling the Functional Contribution of Extracellular Vesicles in Pancreatic Cancer," will investigate the role of cancer cell-derived extracellular vesicles in regulating the tumor microenvironment to facilitate pancreatic cancer initiation, progression, and metastasis. The research...